K. Murano

发表

Structural requirements for the stability of novel cephalosporins to AmpC beta-lactamase based on 3D-structure.

T. Takagi, K. Itoh, K. Murano, 2008, Bioorganic & medicinal chemistry.

Discovery of quinazolinone and quinoxaline derivatives as potent and selective poly(ADP‐ribose) polymerase‐1/2 inhibitors

A. Iwashita, T. Kinoshita, N. Matsuoka, 2005, FEBS letters.

CS-045, a new oral antidiabetic agent, stimulates fructose-2,6-bisphosphate production in rat hepatocytes.

M. Emoto, T. Kaneko, K. Murano, 1994, European journal of pharmacology.

Identification of novel plasminogen activator inhibitor-1 inhibitors with improved oral bioavailability: Structure optimization of N-acylanthranilic acid derivatives.

T. Miyata, Akihisa Maeda, T. Dan, 2018, Bioorganic & medicinal chemistry letters.

Design of a novel dipeptide substance P antagonist FK888

H. Morimoto, H. Miyake, T. Fujii, 1992, Regulatory Peptides.

Flavin-catalyzed aerobic oxidation of sulfides and thiols with formic acid/triethylamine.

Hiroki Iida, S. Murahashi, T. Miyawaki, 2014, Chemical communications.

Discovery of potent and selective PARP-1 and PARP-2 inhibitors: SBDD analysis via a combination of X-ray structural study and homology modeling.

A. Iwashita, T. Kinoshita, N. Matsuoka, 2006, Bioorganic & medicinal chemistry.

Rational approaches to discovery of orally active and brain-penetrable quinazolinone inhibitors of poly(ADP-ribose)polymerase.

Takayoshi Kinoshita, Kenji Murano, Yoshiyuki Kido, 2004, Journal of medicinal chemistry.

Asymmetric Synthesis Using Chiral Acetals : Highly Stereoselective Reduction of Chiral α-Keto-β, γ-unsaturated Acetals and Its Application for the Synthesis of (R)-(-)- and (S)-(+)-3'-Methoxy-4'-O-methyljoubertiamine

Y. Kita, H. Annoura, H. Fujioka, 1989 .

Synthesis and SAR of novel parenteral anti-pseudomonal cephalosporins: discovery of FR264205.

K. Itoh, K. Murano, T. Yamanaka, 2008, Bioorganic & medicinal chemistry letters.